Chargement en cours...
Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria
INTRODUCTION: Oncotype DX assay recurrence score (ODX-RS) cut-off values have recently changed after the publication of the TAILOR-X trial results. We aim to explore decisions for adjuvant chemotherapy (ACT) based on physicians' clinical assessment and the evolving ODX-RS. METHODOLOGY: Patients...
Enregistré dans:
| Publié dans: | Breast Care (Basel) |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger GmbH
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768137/ https://ncbi.nlm.nih.gov/pubmed/33447239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506389 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|